Panrucker D E, Lai P C, Lorscheider F L
Am J Physiol. 1983 Aug;245(2):E138-42. doi: 10.1152/ajpendo.1983.245.2.E138.
Rat acute-phase alpha 2-macroglobulin (AP alpha 2M) concentration was measured by radioimmunoassay in maternal serum, fetal plasma, maternal liver, fetal liver, and amniotic fluid as a function of gestational and neonatal age. The concentration profiles of AP alpha 2M in maternal serum and fetal plasma displayed two peaks, one in early gestation and another during late gestation. Synthesis of AP alpha 2M was confirmed by the immunoprecipitation of [35S]methionine incorporated into cultures of selected tissues. The following observations were made. 1) Maternal serum concentrations of AP alpha 2M were higher than those observed in fetal plasma in early gestation. This was attributable to a high level of maternal AP alpha 2M synthesis in metrial gland which was absent in liver and moderate in yolk sac. 2) In late gestation fetal plasma concentrations of AP alpha 2M greatly exceeded those observed in maternal serum. This could be explained by the pronounced synthesis of AP alpha 2M in fetal liver that was not apparent in maternal liver or yolk sac. 3) During labor, a transient increase in AP alpha 2M concentration was observed in maternal serum and fetal plasma. 4) During lactation a moderately elevated maternal serum concentration of AP alpha 2M was maintained. 5) Amniotic fluid concentration of AP alpha 2M was very low throughout gestation, which indicated that the fetal glomerulus was relatively impermeable to this large protein. It is concluded that in early gestation a principal maternal source of AP alpha 2M appears to be the metrial gland, whereas in late gestation fetal liver is a major source of AP alpha 2M appearing in fetal plasma from where some of this macroglobulin is speculated to be transported to the maternal circulation.
采用放射免疫分析法测定了大鼠急性期α2-巨球蛋白(APα2M)在母血清、胎儿血浆、母肝、胎儿肝脏和羊水中随妊娠和新生儿年龄的变化情况。母血清和胎儿血浆中APα2M的浓度曲线呈现两个峰值,一个在妊娠早期,另一个在妊娠晚期。通过对掺入选定组织培养物中的[35S]甲硫氨酸进行免疫沉淀,证实了APα2M的合成。得到了以下观察结果。1)妊娠早期母血清中APα2M的浓度高于胎儿血浆中的浓度。这归因于子宫腺中高水平的母体APα2M合成,而肝脏中不存在这种合成,卵黄囊中合成水平中等。2)在妊娠晚期,胎儿血浆中APα2M的浓度大大超过母血清中的浓度。这可以解释为胎儿肝脏中APα2M的显著合成,而在母肝或卵黄囊中并不明显。3)分娩期间,母血清和胎儿血浆中APα2M的浓度出现短暂升高。4)哺乳期母血清中APα2M的浓度维持在适度升高水平。5)整个妊娠期羊水中APα2M的浓度非常低,这表明胎儿肾小球对这种大分子蛋白相对不渗透。结论是,在妊娠早期,APα2M的主要母体来源似乎是子宫腺,而在妊娠晚期,胎儿肝脏是胎儿血浆中出现的APα2M的主要来源,据推测,这种巨球蛋白中的一些从胎儿血浆转运到母体循环中。